Skip to main content
Back to Articles

May 3, 2026

As pharma manufacturing gets more automated and more sterile, footwear contamination control becomes a bigger deal than ever

Top of the UVZone shoe sanitizing station showing the READY and WAIT indicators, two footprint windows with lit lamps and the printed instruction to step on footprints to begin

As pharma manufacturing gets more automated and more sterile, footwear contamination control becomes a bigger deal than ever

Pharmaceutical manufacturing is entering a new era. Facilities are becoming more automated, more precise, and more dependent on tightly controlled environments to protect product integrity and patient safety. As robotics, closed systems, and advanced sterile processing reduce some forms of human contact, they also raise the stakes for the contamination risks that remain. One of the most overlooked of those risks is still walking in through the door: footwear.

In a modern pharmaceutical facility, every entry point matters. Floors, corridors, gowning areas, and transition spaces all serve as potential contamination pathways, and shoes are one of the easiest ways for microbial contamination to move from the outside world into critical production zones. That makes footwear sanitation more than a housekeeping issue. It is part of a broader contamination control strategy that helps support cGMP expectations and cleanroom discipline.

Automation changes the risk profile

It brings clear advantages, greater consistency, less direct handling, and fewer opportunities for unnecessary human intervention. In sterile and high-value pharmaceutical manufacturing, that is a powerful step forward. But the more a facility depends on tightly controlled processes, the more important it becomes to manage the contamination risks that still enter through the human interface.

People remain one of the most common sources of contamination in clean environments, and footwear is one of the most practical ways contamination moves from less controlled spaces into more critical ones. Even with proper gowning, shoes still contact the floor, and the floor is often where contamination first settles, builds, and spreads.

So while automation reduces many variables, it does not replace the need for foundational hygiene controls. It raises the value of them. In highly controlled environments, the small, preventable gaps become easier to see, and more important to address.

 

 

Why footwear matters in pharma

Footwear can carry dust, lint, microbes, and chemical residue into areas where even small contamination events can trigger quality issues. That risk becomes especially important in cleanrooms, sterile corridors, fill-finish zones, packaging areas, and biotech operations where environmental control is tied directly to compliance and batch quality. Once contamination is tracked inward, it can affect more than just a surface; it can disrupt workflows, increase cleaning burden, and complicate environmental monitoring.

For pharmaceutical manufacturers, footwear control is also a matter of procedure. A well-designed contamination control program is not just about what happens inside the process equipment. It also includes the movement of people, the condition of the gowning process, and the sanitization of items that cross from low-control to high-control spaces. That is why simple, repeatable interventions can have an outsized effect.

Where UVZone fits

A device that uses UV-C and ozone to sanitize shoe soles

UVZone can help:

●  Reduce shoe-borne contamination at controlled-entry points.

●  Reinforce gowning and hygiene protocols.

●  Support environmental cleanliness in sterile and semi-sterile areas.

●  Improve consistency by making footwear sanitation a standard, repeatable step.

Enhances traditional hygiene protocols

Why this matters for sterile facilities

Sterile manufacturing is built on layers of protection. Cleanrooms, air handling, gowning, monitoring, validated procedures, and sanitation all work together to lower risk. Footwear sanitation strengthens that stack by addressing a contamination pathway that is often underestimated because it is so ordinary.

That is exactly why a tool like UVZone can become part of a facility’s contamination control narrative. It is not a replacement for gowning, shoe covers, cleaning, or environmental monitoring. It is an additional barrier that helps reduce what comes in on shoes before it reaches critical space. In a world where regulators and manufacturers are asking for stronger prevention, that kind of layered control makes sense.

As pharmaceutical manufacturing gets more automated, contamination control has to become more intentional. The more valuable, delicate, and regulated the product becomes, the less tolerance there is for preventable contamination from the facility floor upward. Footwear sanitation may not be flashy (although the UVZone Shoe Sanitizing Station does look pretty cool!), but it is exactly the kind of practical control that modern pharma operations appreciate.

UVZone® is intended to complement a broader contamination-control, hygiene, infection-prevention, or biosecurity program. It does not independently establish compliance or guarantee a facility-specific result.

Application Limits

UVZone® treats the undersides of shoes during an activated treatment cycle. It does not continuously treat the room, the facility, or the footwear after the user steps off the station.

If footwear requires physical cleaning, that cleaning step remains necessary. If your procedure requires chemical treatment, shoe covers, dedicated footwear, hand hygiene, personal protective equipment, environmental cleaning, sanitation, traffic controls, or another facility control, that requirement remains in place until the responsible facility team approves a change.

UVZone® is intended to complement a broader contamination-control, hygiene, infection-prevention, or biosecurity program. It does not independently establish compliance or guarantee a facility-specific result.

Third-Party Lab Verified Efficacy. Selected results shown. Full laboratory reports are available upon request. Testing conducted from 2019 through 2022.

Efficacy claims based on independent laboratory testing. Results may vary based on application conditions. Patho3Gen technology is designed for environmental surface sanitation and is not intended to diagnose, treat, cure, or prevent any disease. Always follow manufacturer guidelines and applicable regulations.

Contact Us